338 related articles for article (PubMed ID: 22081919)
1. Metabolic syndrome and hepatic resection: improving outcome.
Agrawal S; Daruwala C
HPB (Oxford); 2011 Dec; 13(12):846-59. PubMed ID: 22081919
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
3. Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations.
Murtha-Lemekhova A; Fuchs J; Feiler S; Schulz E; Teroerde M; Kalkum E; Klotz R; Billeter A; Probst P; Hoffmann K
BMC Med; 2022 Jan; 20(1):47. PubMed ID: 35101037
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P; Hellerbrand C
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
Younossi ZM; Reyes MJ; Mishra A; Mehta R; Henry L
Aliment Pharmacol Ther; 2014 Jan; 39(1):3-14. PubMed ID: 24206433
[TBL] [Abstract][Full Text] [Related]
6. Use of metabolic syndrome severity to assess treatment with vitamin E and pioglitazone for non-alcoholic steatohepatitis.
Gurka MJ; Mack JA; Chi X; DeBoer MD
J Gastroenterol Hepatol; 2021 Jan; 36(1):249-256. PubMed ID: 32506513
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and chronic liver disease.
Rosselli M; Lotersztajn S; Vizzutti F; Arena U; Pinzani M; Marra F
Curr Pharm Des; 2014; 20(31):5010-24. PubMed ID: 24320032
[TBL] [Abstract][Full Text] [Related]
8. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
Tarantino G; Finelli C
World J Gastroenterol; 2013 Jun; 19(22):3375-84. PubMed ID: 23801829
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
11. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P
J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.
Mayén AL; Sabra M; Aglago EK; Perlemuter G; Voican C; Ramos I; Debras C; Blanco J; Viallon V; Ferrari P; Olsen A; Tjønneland A; Langmann F; Dahm CC; Rothwell J; Laouali N; Marques C; Schulze MB; Katzke V; Kaaks R; Palli D; Macciotta A; Panico S; Tumino R; Agnoli C; Farràs M; Molina-Montes E; Amiano P; Chirlaque MD; Castilla J; Werner M; Bodén S; Heath AK; Tsilidis K; Aune D; Weiderpass E; Freisling H; Gunter MJ; Jenab M
BMC Med; 2024 Jun; 22(1):221. PubMed ID: 38825687
[TBL] [Abstract][Full Text] [Related]
13. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.
Gitto S; de Maria N; di Benedetto F; Tarantino G; Serra V; Maroni L; Cescon M; Pinna AD; Schepis F; Andreone P; Villa E
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):766-773. PubMed ID: 29505475
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
[TBL] [Abstract][Full Text] [Related]
15. Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy.
Paro A; Tsilimigras DI; Dalmacy D; Mirdad RS; Hyer JM; Pawlik TM
J Gastrointest Surg; 2021 Oct; 25(10):2545-2552. PubMed ID: 33547584
[TBL] [Abstract][Full Text] [Related]
16. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
[TBL] [Abstract][Full Text] [Related]
17. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
Cho KI; Jo EA; Cho SH; Kim BH
Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
Kim CH; Younossi ZM
Cleve Clin J Med; 2008 Oct; 75(10):721-8. PubMed ID: 18939388
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
